Is axillary lymph node dissection necessary for positive preoperative aspiration cytology lymph node results?
Based on international guidelines, axillary lymph node dissection (ALND) is recommended in cases of breast cancer if preoperative examinations confirm axillary metastasis. We examined which set of preoperative parameters might render ALND unnecessary. Preoperative examinations (axillary ultrasound a...
Gespeichert in:
| Veröffentlicht in: | European journal of surgical oncology 2020-04, Vol.46 (4), p.504-510 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 510 |
|---|---|
| container_issue | 4 |
| container_start_page | 504 |
| container_title | European journal of surgical oncology |
| container_volume | 46 |
| creator | Horváth, Z. Paszt, A. Simonka, Z. Látos, M. Kaizer, L. Hamar, S. Vörös, A. Ormándi, K. Fejes, Z. Lázár, G. |
| description | Based on international guidelines, axillary lymph node dissection (ALND) is recommended in cases of breast cancer if preoperative examinations confirm axillary metastasis. We examined which set of preoperative parameters might render ALND unnecessary.
Preoperative examinations (axillary ultrasound and aspiration cytology) confirmed axillary metastasis in 190 cases out of 2671 patients with breast cancer; primary ALN dissection was performed on these patients with or without prior neoadjuvant therapy. The clinicopathological results were analysed to determine which parameter might predict the presence of no more than 2 or 3 metastatic ALNs.
The final histological examination confirmed 1–3 metastatic lymph nodes in ALND samples in 116 cases and over 3 metastatic lymph nodes in 74 cases.
For patients receiving neoadjuvant therapy (59 out of the 190 cases), if the size of the primary tumour was 2 cm or smaller and/or the metastatic ALN was 15 mm or smaller, then the patient was likely to have no more than 3 positive ALNs (stage N0–1 disease) (p |
| doi_str_mv | 10.1016/j.ejso.2019.10.043 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2313660428</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0748798319309230</els_id><sourcerecordid>2313660428</sourcerecordid><originalsourceid>FETCH-LOGICAL-c351t-437eda4b59d826ca2d909aaed02edab3b5f98e2200586d989a404b7c3555e5513</originalsourceid><addsrcrecordid>eNp9kEFP3DAUhK0KVBbaP8ChypFLts92nMRSJYRQW5CQuMDZcuy3xaskTv2yiP33dboUiUtPtsczI83H2DmHNQdef92ucUtxLYDrLKyhkh_YiispSsFVc8RW0FRt2ehWnrBToi0AaNnoj-xE8gZaCc2KDbdU2JfQ9zbti34_TE_FGD0WPhChm0McixEdEi3_m5iKKVKYwzMWU8I4YbJ_H5amsFyz3e3n2Mdf79oS0q6f6fITO97YnvDz63nGHn98f7i-Ke_uf95eX92VTio-l5Vs0NuqU9q3onZWeA3aWvQgst7JTm10i0IAqLb2utW2gqprclgpVIrLM3Zx6J1S_L1Dms0QyGFeOWLckRGSy7qGSrTZKg5WlyJRwo2ZUhjyWsPBLJjN1iyYzYJ50TLmHPry2r_rBvRvkX9cs-HbwYB55XPAZMgFHB36kDJW42P4X_8fA0mRIA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2313660428</pqid></control><display><type>article</type><title>Is axillary lymph node dissection necessary for positive preoperative aspiration cytology lymph node results?</title><source>Elsevier ScienceDirect Journals</source><creator>Horváth, Z. ; Paszt, A. ; Simonka, Z. ; Látos, M. ; Kaizer, L. ; Hamar, S. ; Vörös, A. ; Ormándi, K. ; Fejes, Z. ; Lázár, G.</creator><creatorcontrib>Horváth, Z. ; Paszt, A. ; Simonka, Z. ; Látos, M. ; Kaizer, L. ; Hamar, S. ; Vörös, A. ; Ormándi, K. ; Fejes, Z. ; Lázár, G.</creatorcontrib><description>Based on international guidelines, axillary lymph node dissection (ALND) is recommended in cases of breast cancer if preoperative examinations confirm axillary metastasis. We examined which set of preoperative parameters might render ALND unnecessary.
Preoperative examinations (axillary ultrasound and aspiration cytology) confirmed axillary metastasis in 190 cases out of 2671 patients with breast cancer; primary ALN dissection was performed on these patients with or without prior neoadjuvant therapy. The clinicopathological results were analysed to determine which parameter might predict the presence of no more than 2 or 3 metastatic ALNs.
The final histological examination confirmed 1–3 metastatic lymph nodes in ALND samples in 116 cases and over 3 metastatic lymph nodes in 74 cases.
For patients receiving neoadjuvant therapy (59 out of the 190 cases), if the size of the primary tumour was 2 cm or smaller and/or the metastatic ALN was 15 mm or smaller, then the patient was likely to have no more than 3 positive ALNs (stage N0–1 disease) (p < 0.001). If the patient did not receive neoadjuvant therapy, stage N2 or N3 disease was very likely. No correlation was found between other clinicopathological characteristics of the tumour and involvement of the ALNs.
Axillary lymph node dissection is not necessary for selected breast cancer patients with axillary metastasis receiving neoadjuvant therapy. In these cases, sentinel lymph node biopsy with or without radiation therapy and close follow-up may serve as adequate therapy.</description><identifier>ISSN: 0748-7983</identifier><identifier>EISSN: 1532-2157</identifier><identifier>DOI: 10.1016/j.ejso.2019.10.043</identifier><identifier>PMID: 31708307</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Axillary lymph node dissection ; Axillary metastasis ; Breast cancer ; Neoadjuvant therapy</subject><ispartof>European journal of surgical oncology, 2020-04, Vol.46 (4), p.504-510</ispartof><rights>2019</rights><rights>Copyright © 2019. Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c351t-437eda4b59d826ca2d909aaed02edab3b5f98e2200586d989a404b7c3555e5513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0748798319309230$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31708307$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Horváth, Z.</creatorcontrib><creatorcontrib>Paszt, A.</creatorcontrib><creatorcontrib>Simonka, Z.</creatorcontrib><creatorcontrib>Látos, M.</creatorcontrib><creatorcontrib>Kaizer, L.</creatorcontrib><creatorcontrib>Hamar, S.</creatorcontrib><creatorcontrib>Vörös, A.</creatorcontrib><creatorcontrib>Ormándi, K.</creatorcontrib><creatorcontrib>Fejes, Z.</creatorcontrib><creatorcontrib>Lázár, G.</creatorcontrib><title>Is axillary lymph node dissection necessary for positive preoperative aspiration cytology lymph node results?</title><title>European journal of surgical oncology</title><addtitle>Eur J Surg Oncol</addtitle><description>Based on international guidelines, axillary lymph node dissection (ALND) is recommended in cases of breast cancer if preoperative examinations confirm axillary metastasis. We examined which set of preoperative parameters might render ALND unnecessary.
Preoperative examinations (axillary ultrasound and aspiration cytology) confirmed axillary metastasis in 190 cases out of 2671 patients with breast cancer; primary ALN dissection was performed on these patients with or without prior neoadjuvant therapy. The clinicopathological results were analysed to determine which parameter might predict the presence of no more than 2 or 3 metastatic ALNs.
The final histological examination confirmed 1–3 metastatic lymph nodes in ALND samples in 116 cases and over 3 metastatic lymph nodes in 74 cases.
For patients receiving neoadjuvant therapy (59 out of the 190 cases), if the size of the primary tumour was 2 cm or smaller and/or the metastatic ALN was 15 mm or smaller, then the patient was likely to have no more than 3 positive ALNs (stage N0–1 disease) (p < 0.001). If the patient did not receive neoadjuvant therapy, stage N2 or N3 disease was very likely. No correlation was found between other clinicopathological characteristics of the tumour and involvement of the ALNs.
Axillary lymph node dissection is not necessary for selected breast cancer patients with axillary metastasis receiving neoadjuvant therapy. In these cases, sentinel lymph node biopsy with or without radiation therapy and close follow-up may serve as adequate therapy.</description><subject>Axillary lymph node dissection</subject><subject>Axillary metastasis</subject><subject>Breast cancer</subject><subject>Neoadjuvant therapy</subject><issn>0748-7983</issn><issn>1532-2157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kEFP3DAUhK0KVBbaP8ChypFLts92nMRSJYRQW5CQuMDZcuy3xaskTv2yiP33dboUiUtPtsczI83H2DmHNQdef92ucUtxLYDrLKyhkh_YiispSsFVc8RW0FRt2ehWnrBToi0AaNnoj-xE8gZaCc2KDbdU2JfQ9zbti34_TE_FGD0WPhChm0McixEdEi3_m5iKKVKYwzMWU8I4YbJ_H5amsFyz3e3n2Mdf79oS0q6f6fITO97YnvDz63nGHn98f7i-Ke_uf95eX92VTio-l5Vs0NuqU9q3onZWeA3aWvQgst7JTm10i0IAqLb2utW2gqprclgpVIrLM3Zx6J1S_L1Dms0QyGFeOWLckRGSy7qGSrTZKg5WlyJRwo2ZUhjyWsPBLJjN1iyYzYJ50TLmHPry2r_rBvRvkX9cs-HbwYB55XPAZMgFHB36kDJW42P4X_8fA0mRIA</recordid><startdate>202004</startdate><enddate>202004</enddate><creator>Horváth, Z.</creator><creator>Paszt, A.</creator><creator>Simonka, Z.</creator><creator>Látos, M.</creator><creator>Kaizer, L.</creator><creator>Hamar, S.</creator><creator>Vörös, A.</creator><creator>Ormándi, K.</creator><creator>Fejes, Z.</creator><creator>Lázár, G.</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202004</creationdate><title>Is axillary lymph node dissection necessary for positive preoperative aspiration cytology lymph node results?</title><author>Horváth, Z. ; Paszt, A. ; Simonka, Z. ; Látos, M. ; Kaizer, L. ; Hamar, S. ; Vörös, A. ; Ormándi, K. ; Fejes, Z. ; Lázár, G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c351t-437eda4b59d826ca2d909aaed02edab3b5f98e2200586d989a404b7c3555e5513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Axillary lymph node dissection</topic><topic>Axillary metastasis</topic><topic>Breast cancer</topic><topic>Neoadjuvant therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Horváth, Z.</creatorcontrib><creatorcontrib>Paszt, A.</creatorcontrib><creatorcontrib>Simonka, Z.</creatorcontrib><creatorcontrib>Látos, M.</creatorcontrib><creatorcontrib>Kaizer, L.</creatorcontrib><creatorcontrib>Hamar, S.</creatorcontrib><creatorcontrib>Vörös, A.</creatorcontrib><creatorcontrib>Ormándi, K.</creatorcontrib><creatorcontrib>Fejes, Z.</creatorcontrib><creatorcontrib>Lázár, G.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Horváth, Z.</au><au>Paszt, A.</au><au>Simonka, Z.</au><au>Látos, M.</au><au>Kaizer, L.</au><au>Hamar, S.</au><au>Vörös, A.</au><au>Ormándi, K.</au><au>Fejes, Z.</au><au>Lázár, G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is axillary lymph node dissection necessary for positive preoperative aspiration cytology lymph node results?</atitle><jtitle>European journal of surgical oncology</jtitle><addtitle>Eur J Surg Oncol</addtitle><date>2020-04</date><risdate>2020</risdate><volume>46</volume><issue>4</issue><spage>504</spage><epage>510</epage><pages>504-510</pages><issn>0748-7983</issn><eissn>1532-2157</eissn><abstract>Based on international guidelines, axillary lymph node dissection (ALND) is recommended in cases of breast cancer if preoperative examinations confirm axillary metastasis. We examined which set of preoperative parameters might render ALND unnecessary.
Preoperative examinations (axillary ultrasound and aspiration cytology) confirmed axillary metastasis in 190 cases out of 2671 patients with breast cancer; primary ALN dissection was performed on these patients with or without prior neoadjuvant therapy. The clinicopathological results were analysed to determine which parameter might predict the presence of no more than 2 or 3 metastatic ALNs.
The final histological examination confirmed 1–3 metastatic lymph nodes in ALND samples in 116 cases and over 3 metastatic lymph nodes in 74 cases.
For patients receiving neoadjuvant therapy (59 out of the 190 cases), if the size of the primary tumour was 2 cm or smaller and/or the metastatic ALN was 15 mm or smaller, then the patient was likely to have no more than 3 positive ALNs (stage N0–1 disease) (p < 0.001). If the patient did not receive neoadjuvant therapy, stage N2 or N3 disease was very likely. No correlation was found between other clinicopathological characteristics of the tumour and involvement of the ALNs.
Axillary lymph node dissection is not necessary for selected breast cancer patients with axillary metastasis receiving neoadjuvant therapy. In these cases, sentinel lymph node biopsy with or without radiation therapy and close follow-up may serve as adequate therapy.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>31708307</pmid><doi>10.1016/j.ejso.2019.10.043</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0748-7983 |
| ispartof | European journal of surgical oncology, 2020-04, Vol.46 (4), p.504-510 |
| issn | 0748-7983 1532-2157 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2313660428 |
| source | Elsevier ScienceDirect Journals |
| subjects | Axillary lymph node dissection Axillary metastasis Breast cancer Neoadjuvant therapy |
| title | Is axillary lymph node dissection necessary for positive preoperative aspiration cytology lymph node results? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T12%3A56%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20axillary%20lymph%20node%20dissection%20necessary%20for%20positive%20preoperative%20aspiration%20cytology%20lymph%20node%20results?&rft.jtitle=European%20journal%20of%20surgical%20oncology&rft.au=Horv%C3%A1th,%20Z.&rft.date=2020-04&rft.volume=46&rft.issue=4&rft.spage=504&rft.epage=510&rft.pages=504-510&rft.issn=0748-7983&rft.eissn=1532-2157&rft_id=info:doi/10.1016/j.ejso.2019.10.043&rft_dat=%3Cproquest_cross%3E2313660428%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2313660428&rft_id=info:pmid/31708307&rft_els_id=S0748798319309230&rfr_iscdi=true |